G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 27.75 SEK 3.74% Market Closed
Market Cap: 1.8B SEK
Have any thoughts about
Genovis AB?
Write Note

Genovis AB
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genovis AB
Other Current Liabilities Peer Comparison

Comparables:
ALIF B
BICO
BIOT
MCAP
M
MAGLE

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
G
Genovis AB
STO:GENO
Other Current Liabilities
kr16.3m
CAGR 3-Years
7%
CAGR 5-Years
9%
CAGR 10-Years
11%
AddLife AB
STO:ALIF B
Other Current Liabilities
kr490m
CAGR 3-Years
14%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Other Current Liabilities
kr378.6m
CAGR 3-Years
120%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Other Current Liabilities
kr546m
CAGR 3-Years
37%
CAGR 5-Years
89%
CAGR 10-Years
52%
MedCap AB (publ)
STO:MCAP
Other Current Liabilities
kr41.9m
CAGR 3-Years
41%
CAGR 5-Years
30%
CAGR 10-Years
16%
M
Magle Chemoswed Holding AB
STO:MAGLE
Other Current Liabilities
kr13.5m
CAGR 3-Years
12%
CAGR 5-Years
-29%
CAGR 10-Years
N/A

See Also

What is Genovis AB's Other Current Liabilities?
Other Current Liabilities
16.3m SEK

Based on the financial report for Jun 30, 2024, Genovis AB's Other Current Liabilities amounts to 16.3m SEK.

What is Genovis AB's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
11%

Over the last year, the Other Current Liabilities growth was 1%. The average annual Other Current Liabilities growth rates for Genovis AB have been 7% over the past three years , 9% over the past five years , and 11% over the past ten years .

Back to Top